Oligoclonal T cell expansion in myelodysplastic syndrome: evidence for an autoimmune process
Oligoclonal T cell expansion in myelodysplastic syndrome: evidence for an autoimmune process
复制标题
DOI:
10.1016/s0145-2126(01)00083-2
复制
发表时间:
2001-12-01
影响因子:
2.7
通讯作者:
Barrett, AJ
中科院分区:
文献类型:
--
作者:
Epperson, DE;Nakamura, R;Barrett, AJ
There is accumulating evidence that the marrow-failure of myelodysplastic syndrome (MDS) is immune-mediated. We studied patients with MDS to look for oligoclonal or clonal. expansion in T cells indicative of an autoimmune process. We used a PCR-based technique (spectratyping) to characterize the T cell repertoire in MDS (n = 15; 9 RA, 4 RARS, 2 RAEB) and compared results with age-matched healthy donors (n = 20) and transfusion-dependent (TD) patients with hemoglobinopathy (n = 5). We found a significantly higher number of skewed V beta profiles in the MDS patients compared with controls. In peripheral blood T cells, 60/345 V beta profiles examined were skewed in MDS patients compared with 3/115 V beta profiles in TD controls (P < 0.0001), and 58/460 V beta profiles in age-matched controls (P = 0.05). A study of J beta region within the skewed V beta profiles revealed preferential usage of J beta 2.1 in MDS in contrast with a wide distribution over the entire J beta spectrum in controls, consistent with non-random T cell clonal. expansion in MDS. These findings provide further evidence that T cell mediated immune processes are a feature of MDS. Published by Elsevier Science Ltd.